A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Samuel Blumenthal, MD
Collaborative Study Group
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
56 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Department of Nephrology and Hypertension Brazilai Medical Center
Ashkelon, Israel
- Tel Aviv Sourasky Medical Center Nephrology Department
Tel Aviv, Israel
- Rcmi-Clinical Research Center Medical Sciences Campus University of Puerto Rico
Rio Piedras, PR, Puerto Rico
- Puerto Rico Renal Health & Research Center, Inc/ Atlantic Healthcare Group, Inc
Trujillo Alto, PR, Puerto Rico
- Southwest Clinical Research Institute, Llc
Tempe, Arizona, United States
- Tower Nephrology Medical Group
Los Angeles, California, United States
- Veterans Administration Greater Los Angeles Healthcare System, West Los Angeles
Los Angeles, California, United States
- Apex Research of Riverside
Riverside, California, United States
- American Institute of Research
Whittier, California, United States
- University of Colorado Denver
Aurora, Colorado, United States
- Western Nephrology
Westminster, Colorado, United States
- Pab Clinical Research
Brandon, Florida, United States
- Mayo Clinic
Jacksonville, Florida, United States
- Asa Clinical Research, Llc
Jupiter, Florida, United States
- Ocala Kidney Group
Ocala, Florida, United States
- Pines Clinical Research, Inc.
Pembroke Pines, Florida, United States
- Kidney Care Associates, Llc
Augusta, Georgia, United States
- Atlanta Nephrology Referral Center
Decatur, Georgia, United States
- Circle Medical Management
Chicago, Illinois, United States
- Nephrology Specialists, Pc
Michigan City, Indiana, United States
- Lsu Health Sciences Center Section of Nephrology and Hypertension Department of Internal Medicine
New Orleans, Louisiana, United States
- Rockville Dialysis Center
Rockville, Maryland, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Pioneer Valley Nephrology
Holyoke, Massachusetts, United States
- Western New England Renal & Transplant Associates
Springfield, Massachusetts, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Michigan Kidney Consultants, Pc
Pontiac, Michigan, United States
- Nephrology Hypertension Clinic
Southgate, Michigan, United States
- Kansas City Va Medical Center
Kansas City, Missouri, United States
- Brookdale Physician'S Dialysis Associates
Brooklyn, New York, United States
- Mountain Kidney and Hypertension Associates, Pa
Asheville, North Carolina, United States
- Metrolina Nephrology Associates, Pa
Charlotte, North Carolina, United States
- Duke University Medical Center Division of Nephrology
Durham, North Carolina, United States
- Trial Management Associates
Wilmington, North Carolina, United States
- Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States
- Clinical Research Limited
Canton, Ohio, United States
- Division of Nephrology and Hypertension Department of Internal Medicine University of Cincinnati College of Medicine
Cincinnati, Ohio, United States
- Cleveland Clinic Foundation Q7-150 Nephrology
Cleveland, Ohio, United States
- the Ohio State University Division of Nephrology
Columbus, Ohio, United States
- Davita
Oklahoma City, Oklahoma, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2010
- Primary completion
- 31 Jan 2013
- Completion
- 28 Feb 2013
- Last update posted
- 10 Dec 2014
- Registered enrollment
- 441
- Registry id
- NCT01191255
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.